450 Anti-Diphtheria Serum to arrive at MVID Hospital

Beauty & Health

The newly appointed Medical Superintendent of the Maharishi Valmiki Infectious Diseases Hospital (MVID) on Thursday confirmed that the hospital is expecting another 450 serums, while there are 100 already in the stock. The information came at a time when the death toll reached 21 after another death Wednesday evening.

Over 500 cases of Diphtheria have been reported in Delhi this year. Of these, 21 out of the 170 admitted died at the North Delhi Municipal Corporation-run Maharishi Valmiki Infectious Diseases Hospital between September 6 and 26. 2017 saw a rise in cases as compared to the previous years, this year too there has been a rise in the cases.

The first round of 200 serums had been procured from Central Research Institute in Kasauli and now these are also being procured from a distributor in Hyderabad.

“We had sent 200 serums earlier, but now we are short of it ourselves, the next round will be able to send only by October 18th,” said a senior official at the Central Research Institute, Kasauli.

North Delhi Mayor Adesh Gupta, on Tuesday, had suspended medical superintendent of the hospital for alleged lapses in connection with the death of the children at the facility, he had also approached Union Health Minister J P Nadda in the wake of diphtheria deaths, for supply of anti-diphtheria serum (ADS) .

“There were lapses, it seems, so we have taken the action. Rest action will depend on what comes out in the report,” he said.

Then Medical Superintendent Sunil Kumar Gupta on September 20 had said that the patients belonged to age group of up to 9 years and of the total admitted patients, 122 belonged to Uttar Pradesh, 11 from Haryana and 14 from Delhi.

Diphtheria cases occur only in this season and such a number of cases in the season is “not unusual”, said Gupta.

Leave a Reply